¼¼°èÀÇ À¯ÀüÇÐÀû °Ë»ç ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)
Hereditary Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1665102
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 130 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,767,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,442,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,651,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ À¯ÀüÇÐÀû °Ë»ç ½ÃÀåÀº 2024³â 76¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.7%·Î °ßÁ¶ÇÏ°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

À¯ÀüÇÐÀû °Ë»ç´Â Á¾Á¾ À¯ÀüÀÚ °Ë»ç¶ó°í ºÒ¸®¸ç, °³ÀÎÀÇ DNA¸¦ ºÐ¼®ÇÏ¿© ºÎ¸ð·ÎºÎÅÍ »ó¼ÓµÈ À¯ÀüÀÚ, ¿°»öü ¹× ´Ü¹éÁúÀÇ µ¹¿¬º¯À̸¦ °ËÃâÇÕ´Ï´Ù. ÀÌ È¹±âÀûÀÎ ±â¼úÀº À¯Àü ÁúȯÀ» È®ÀÎÇϰí Á¶±â Áø´ÜÀ» °¡´ÉÇÏ°Ô Çϰí À§Çè ¿äÀÎÀ» Æò°¡ÇÏ¸ç °³Àο¡ ¸Â´Â Ä¡·á °èȹÀ» ¼¼¿ì´Â µ¥ Á¡Á¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ±Þ¼ºÀåÀº À¯Àüü ¿¬±¸¿Í ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ À¯ÀüÀÚ °Ë»ç°¡ ´õ ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î ´õ ¸¹Àº »ç¶÷µéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ÀÏ»óÀûÀÎ °Ç°­ °ü¸®¿¡ ´ëÇÑ ÅëÇÕÀÌ ÁøÇàµÊ¿¡ µû¶ó Á¤ºÎÀÇ È£ÀÇÀû Á¤Ã¥°ú °Ç°­ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó À¯ÀüÇÐÀû °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä´Â Àü·Ê¾øÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

Hereditary Testing Market-IMG1

°³ÀÎÈ­µÈ ÀÇ·á°¡ ±â¼¼¸¦ ´Ã¸®´Â µ¿¾È, À¯ÀüÇÐÀû °Ë»ç´Â Á¤¹Ð °Ç°­ °ü¸®ÀÇ Ãʼ®À¸·Î ÀÚ¸®¸Å±èÇϰí, Àǻ簡 À¯ÀüÀÚ Á¤º¸¸¦ ±â¹ÝÀ¸·Î Ä¡·á¸¦ ¸ÂÃãÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ µ¿ÇâÀº Ãâ»ý Àü ½ºÅ©¸®´×, Áúº´ ¿¹Ãø, ¾Ï À§Çè Æò°¡ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ À¯ÀüÀÚ °Ë»çÀÇ ÀÌ¿ë È®´ë·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÖÇø®ÄÉÀ̼ÇÀº Çö´ë °Ç°­ °ü¸®¸¦ º¯È­½Ã۰í Á¶±â °³ÀÔÀ» ÃËÁøÇϰí Àå±âÀûÀÎ °Ç°­ °á°ú¸¦ °³¼±Çϱâ À§ÇØ À¯ÀüÀÚ °Ë»çÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù. °Ô´Ù°¡ À¯ÀüÀû Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿Í º¸ÇèÁö¿ø°ú »óȯÁ¤Ã¥¿¡ ÀÇÇÑ Á¢±Ù¼º Çâ»óÀÌ ÇÔ²² ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 76¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 159¾ï ´Þ·¯
CAGR 7.7%

Áúº´ À¯Çüº°·Î º¸¸é ½ÃÀåÀº À¯Àü¼º ¾Ï °Ë»ç¿Í À¯Àü¼º ºñ¾Ï °Ë»ç·Î ³ª´¹´Ï´Ù. 2024³â¿¡´Â À¯Àü¼º ºñ¾Ï °Ë»ç°¡ ½ÃÀåÀ» ¼®±ÇÇØ 55¾ï ´Þ·¯ÀÇ ¼öÀÍÀ» ¿Ã·È½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä ±ÞÁõÀÇ ¹è°æ¿¡´Â À¯Àü¼º Áúȯ¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í Á¶±â ¹ß°ßÀÇ Á߿伺 Áõ°¡°¡ ÀÖ½À´Ï´Ù. ȯÀÚ¿Í °Ç°­ °ü¸® Á¦°ø¾÷ü ¸ðµÎ ¿¹¹æÀû À¯ÀüÀÚ ½ºÅ©¸®´×°ú »ó´ãÀ» Áß½ÃÇÏ°í ¿¹¹æÀû °Ç°­ °ü¸® Àü·«À¸·ÎÀÇ ÀüȯÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

±â¼úÀûÀ¸·Î ½ÃÀåÀº ¼¼Æ÷À¯ÀüÇÐÀû °Ë»ç, »ýÈ­ÇÐÀû °Ë»ç, ºÐÀÚ°Ë»ç·Î ºÐ·ùµÇ¸ç, 2024³â¿¡´Â ºÐÀڰ˻簡 54.1%·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ºÐ¾ß´Â °Ë»ç Á¤¹Ðµµ¿Í È¿À²¼ºÀ» Çâ»ó½ÃŲ ¸ÖƼÇ÷º½º PCR ºÐ¼®°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ±â¼úÀº ¿©·¯ À¯ÀüÀÚ µ¹¿¬º¯ÀÌÀÇ µ¿½Ã °ËÃâÀ» °¡´ÉÇÏ°Ô ÇÏ°í ºñ¿ë°ú ³³±â¸¦ ÁÙ¿©ÁÝ´Ï´Ù. ¶ÇÇÑ, ºÐÀÚ °Ë»ç Ç÷§Æû¿¡¼­ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº µ¥ÀÌÅÍ ºÐ¼®À» °£¼ÒÈ­Çϰí, À¯ÀüÀÚ º¯ÇüÀÇ ºÐ·ù¸¦ °­È­Çϰí, ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ ½ÃÀ常À¸·Îµµ À¯Àü¼º °Ë»ç ½ÃÀåÀº 2024³â 22¾ï ´Þ·¯¿¡ ´ÞÇß°í, ¾ÕÀ¸·Îµµ »ó½Â ±âÁ¶¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ³ª¶ó¿¡¼­´Â À¯Àü¼º Áúȯ°ú À¯Àü¼º ¾ÏÀÇ À¯º´·üÀÌ »ó½ÂÇϰí ÀÖÀ¸¸ç, À¯ÀüÀÚ °Ë»ç ¼­ºñ½º ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. º¸Çè Àû¿ë ¹üÀ§ÀÇ È®´ë¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥¿¡ ÀÇÇØ À¯ÀüÀÚ °Ë»ç°¡ º¸´Ù Ä£¼÷ÇØÁö°í µµÀÔÀÌ °¡¼ÓµÇ°í ÀÖ½À´Ï´Ù. À¯Àüü ¿¬±¸ÀÇ Áö¼ÓÀûÀÎ ÁøÀü°ú ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó À¯ÀüÇÐÀû °Ë»ç ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ç¸ç ¼¼°è °Ç°­ °á°ú °³¼±¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߰衤¿¹Ãø : Áúȯ À¯Çüº°, 2021-2034³â

Á¦6Àå ½ÃÀå Ã߰衤¿¹Ãø : ±â¼úº°, 2021-2034³â

Á¦7Àå ½ÃÀå Ã߰衤¿¹Ãø : Áö¿ªº°, 2021-2034³â

Á¦8Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Hereditary Testing Market, valued at USD 7.6 billion in 2024, is projected to grow at a robust CAGR of 7.7% from 2025 to 2034. Hereditary testing, often referred to as genetic testing, analyzes an individual's DNA to detect gene, chromosome, or protein mutations inherited from parents. This revolutionary technology plays an increasingly pivotal role in identifying genetic conditions, enabling early diagnoses, assessing risk factors, and tailoring personalized treatment plans for individuals. The market's rapid growth can be attributed to advancements in genomic research and technology, which have made genetic testing more affordable and accessible to a wider population. With greater integration into everyday healthcare practices and supported by favorable government policies and increasing health awareness, the demand for hereditary testing is at an all-time high.

Hereditary Testing Market - IMG1

As personalized medicine gains momentum, hereditary testing is positioned as a cornerstone of precision healthcare, helping doctors customize treatments based on genetic information. This trend has led to the growing use of genetic tests in diverse areas like prenatal screening, disease prediction, and cancer risk evaluation. These applications are transforming modern healthcare, emphasizing the need for genetic testing to facilitate early interventions and improve long-term health outcomes. Additionally, growing awareness of genetic conditions, combined with improved accessibility due to insurance support and reimbursement policies, has contributed significantly to the market's expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$7.6 Billion
Forecast Value$15.9 Billion
CAGR7.7%

By disease type, the market is divided into hereditary cancer testing and hereditary non-cancer testing. In 2024, hereditary non-cancer testing dominated the market, generating USD 5.5 billion in revenue. This surge in demand is driven by increased awareness of genetic disorders and the growing importance of early detection. Patients and healthcare providers alike are placing more emphasis on proactive genetic screening and counseling, leading to a shift toward preventive healthcare strategies.

Technologically, the market is categorized into cytogenetic, biochemical, and molecular testing, with molecular testing holding the largest market share at 54.1% in 2024. This segment is expected to experience substantial growth during the forecast period, thanks to innovations like multiplex PCR assays that have improved testing accuracy and efficiency. These advanced technologies enable the simultaneous detection of multiple genetic variants, reducing both costs and turnaround times. Additionally, the integration of artificial intelligence and machine learning in molecular testing platforms is streamlining data interpretation, enhancing genetic variant classification, and further driving market growth.

In the U.S. alone, the hereditary testing market reached USD 2.2 billion in 2024 and is expected to maintain its upward trajectory. The rising prevalence of genetic disorders and hereditary cancers in the country is fueling the demand for genetic testing services. Enhanced insurance coverage and favorable reimbursement policies are making genetic testing more accessible, accelerating adoption. With ongoing advancements in genomic research and a growing focus on personalized medicine, the hereditary testing market is poised for continued growth, playing a crucial role in improving health outcomes worldwide.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 – 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

Chapter 8 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â